GT Biopharma, Inc. Business Finance Contracts & Agreements
106 Contracts & Agreements
- Debenture Agreements (10 contracts)
- Escrow Agreements (1)
- Exchange Agreements (3)
- Forbearance Agreements (4)
- Note Agreements (27)
- Purchase Agreements (20)
- Registration Rights Agreements (8)
- Security Agreements (2)
- Stock Agreements (7)
- Underwriting Agreements (1)
- Warrant Agreements (23)
- Form of Securities Purchase Agreement, dated May 21, 2024 (Filed With SEC on May 23, 2024)
- Form of Common Warrant (Filed With SEC on May 23, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 4, 2023)
- Form of Placement Agent Warrant (Filed With SEC on January 4, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on January 4, 2023)
- Form of Common Warrant (Filed With SEC on January 4, 2023)
- Certificate of Designation of Preferences, Rights and Limitations of Series K Preferred Stock of GT Biopharma, Inc., dated April 3, 2019 (Filed With SEC on April 16, 2021)
- Form of December 2020 / January 2021 Note (Filed With SEC on February 9, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on February 9, 2021)
- Amendment to Convertible Note, effective as of January 31, 2021, by and between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (Filed With SEC on February 9, 2021)
- Form of December 2020 / January 2021 Note (Filed With SEC on February 8, 2021)
- Form of Securities Purchase Agreement - December 2020 / January 2021 Notes (Filed With SEC on February 8, 2021)
- Amendment to Settlement Note with Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (Filed With SEC on February 8, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 8, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on February 2, 2021)
- Form of Warrant (Filed With SEC on February 2, 2021)
- Form of Amendment to Convertible Note, dated as of January 31, 2021 (Filed With SEC on February 2, 2021)
- Form of Second Amendment and Extension of Standstill and Forbearance Agreement (Filed With SEC on February 2, 2021)
- CONVERTIBLE NOTE DUE JANUARY 31, 2021 (Filed With SEC on December 28, 2020)
- AMENDMENT TO CONVERTIBLE NOTE & STANDSTILLAGREEMENT (Filed With SEC on December 23, 2020)
- Form of Settlement Note, dated November 9, 2020 (Filed With SEC on November 13, 2020)
- Securities Purchase Agreement (Filed With SEC on November 9, 2020)
- Form of Secured Convertible Note (Filed With SEC on November 9, 2020)
- Securities Purchase Agreement (Filed With SEC on September 22, 2020)
- Form of Secured Convertible Note (Filed With SEC on September 22, 2020)
- Registration Rights Agreement (Filed With SEC on July 9, 2020)
- Securities Purchase Agreement (Filed With SEC on July 9, 2020)
- Form of Secured Convertible Note (Filed With SEC on July 9, 2020)
- STANDSTILL AND FORBEARANCE AGREEMENT (Filed With SEC on June 23, 2020)
- Form of Pre-Funded Warrant to Purchase Common Stock, dated June 19, 2020 (included in Exhibit 10.1) (Filed With SEC on June 19, 2020)
- Form of Convertible Note, dated June 19, 2020 (included in Exhibit 10.1) (Filed With SEC on June 19, 2020)
- Form of Note, dated April/May, 2020 (Filed With SEC on May 15, 2020)
- Form of Registration Rights Agreement by and among the Company and the Buyers, dated April/May, 2020 (Filed With SEC on May 15, 2020)
- Securities Purchase Agreement by and among the Company and the Buyers, dated April/May, 2020 (Filed With SEC on May 15, 2020)
- Form of Note, dated January 30, 2020 (Filed With SEC on May 15, 2020)
- Form of Registration Rights Agreement by and among the Company and the Buyers, dated January 30, 2020 (Filed With SEC on May 15, 2020)
- Securities Purchase Agreement by and among the Company and the Buyers, dated January 30, 2020 (Filed With SEC on May 15, 2020)
- Registration Rights Agreement (Filed With SEC on August 23, 2019)
- Securities Purchase Agreement (Filed With SEC on August 23, 2019)
- Form of Secured Convertible Note (Filed With SEC on August 23, 2019)
